Clinical Trial Detail

NCT ID NCT01835288
Title Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements no
Sponsors Stanford University
Indications

acute myeloid leukemia

Therapies

Arsenic trioxide

Age Groups: adult

No variant requirements are available.